ProPhase Labs Competitors and Similar CompaniesClear all

ProPhase Labs's competitors and similar companies include Echo Healthcare, Delta-Fly Pharma, Nitrase Therapeutics and MigVax.

	ProPhase Labs ProPhase Labs develops and markets clinically proven remedies including the highly effective Cold-EEZE and Kids-EEZE product lines.	Echo Healthcare Echo Healthcare is a company that provides medical simulation, education, and training systems.	Delta-Fly Pharma Delta-Fly Pharma 株式会社（デルタフライファーマ is a manufacturer and seller of anti-cancer agents and other products.	Nitrase Therapeutics Nitrase Therapeutics is a biotech company intended to develop drugs against a new class of enzymes targeting Parkinson's disease.	MigVax MigVax is a medical technology company.
Founding Date	Founding Date 1981	Founding Date 2018	Founding Date 2010	Founding Date 2012	Founding Date N/A
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare Manufacturing & Industrial drug development healthtech medtech	Tags Healthcare edtech medical devices simulation	Tags Healthcare drug development medtech	Tags Healthcare biotech drug development healthtech medtech	Tags Healthcare biotech drug development healthtech medtech pharma
Locations	Locations Doylestown, US HQ Old Bridge, US Uniondale, US	Locations Sarasota, US HQ	Locations HQ	Locations Brisbane, US HQ	Locations Qiryat Shemona, IL HQ
Employees	Employees 477% increase	Employees 343% increase	Employees N/A	Employees N/A	Employees N/A
Valuation ($)	Valuation ($) 42.9 m	Valuation ($) N/A	Valuation ($) 29.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $6.8m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $6.9m (FY, 2024)	Cost of goods N/A	Cost of goods (¥1.6m) (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ($150k) (FY, 2024)	Gross profit N/A	Gross profit ¥1.6m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($53.4m) (FY, 2024)	Net income N/A	Net income (¥1.7b) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 38m (about 6 years ago)	Latest funding round $ 12m (about 6 years ago)
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 38.1m	Total funding raised $ 12m